An extremely indolent T-cell leukemia: an 18-year follow-up
The Journal of Community and Supportive Oncology · 2016-02 · 76-78
DOI: 10.12788/jcso.0190 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2016-02. Verfasst von Samuel Adediran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania, USA. samuel.adediran@lvhn.org. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania, USA. samuel.adediran@lvhn.org.
- Department of Pathology and Laboratory Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania, USA.
- Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA.
- Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania, USA.
- Division of Hematology/Medical Oncology, Lehigh Valley Hospital, Allentown, Pennsylvania, USA.
Zitieren
APA
Adediran, S., Cornfield, D., Bagg, A., & Agostino, N. (2016). An extremely indolent T-cell leukemia: an 18-year follow-up. The Journal of Community and Supportive Oncology, 76-78. https://doi.org/10.12788/jcso.0190
Vancouver
Adediran S, Cornfield D, Bagg A, Agostino N. An extremely indolent T-cell leukemia: an 18-year follow-up. The Journal of Community and Supportive Oncology. 2016:76-78. doi:10.12788/jcso.0190
BibTeX
@article{Adediran2016,
author = {Adediran, Samuel and Cornfield, Dennis and Bagg, Adam and Agostino, Nicole},
title = {An extremely indolent T-cell leukemia: an 18-year follow-up},
journal = {The Journal of Community and Supportive Oncology},
year = {2016},
pages = {76--78},
doi = {10.12788/jcso.0190}
}
EUVIMED